The Arterial Baroreflex Effectiveness Index in Risk Stratification of Chronic Heart Failure Patients Who Are Candidates for Cardiac Resynchronization Therapy
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.17/3009 |
Resumo: | INTRODUCTION: Baroreflex function is an independent marker of prognosis in heart failure (HF). However, little is known about its relation to response to cardiac resynchronization therapy (CRT). The aim of this study is to assess arterial baroreflex function in HF patients who are candidates for CRT. METHODS: The study population consisted of 25 patients with indication for CRT, aged 65±10 years, NYHA functional class ≥III in 52%, QRS width 159±15 ms, left ventricular ejection fraction (LVEF) 29±5%, left ventricular end-systolic volume (LVESV) 150±48 ml, B-type natriuretic peptide (BNP) 357±270 pg/ml, and peak oxygen consumption (peak VO2) 18.4±5.0 ml/kg/min. An orthostatic tilt test was performed to assess the baroreflex effectiveness index (BEI) by the sequence method. This group was compared with 15 age-matched healthy individuals. RESULTS: HF patients showed a significantly depressed BEI during tilt (31±12% vs. 49±18%, p=0.001). A lower BEI was associated with higher BNP (p=0.038), lower peak VO2 (p=0.048), and higher LVESV (p=0.031). By applying a cut-off value of 25% for BEI, two clusters of patients were identified: lower risk cluster (BEI >25%) QRS 153 ms, LVESV 129 ml, BNP 146 pg/ml, peak VO2 19.0 ml/kg/min; and higher risk cluster (IEB ≤25%) QRS 167 ms, LVESV 189 ml, BNP 590 pg/ml, peak VO2 16.2 ml/kg/min. CONCLUSIONS: Candidates for CRT show depressed arterial baroreflex function. Lower BEI was observed in high-risk HF patients. Baroreflex function correlated closely with other clinical HF parameters. Therefore, BEI may improve risk stratification in HF patients undergoing CRT. |
id |
RCAP_e82f1669b08ad7d33901f1342db743cd |
---|---|
oai_identifier_str |
oai:repositorio.chlc.min-saude.pt:10400.17/3009 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
The Arterial Baroreflex Effectiveness Index in Risk Stratification of Chronic Heart Failure Patients Who Are Candidates for Cardiac Resynchronization TherapyO Índice de Eficácia do Barorreflexo na Estratificação de Risco de Doentes com Insuficiência Cardíaca Crónica Candidatos à Terapêutica de Ressincronização CardíacaAgedFemaleHeart FailureHumansMaleMiddle AgedNatriuretic Peptide, BrainRisk AssessmentStroke VolumeTreatment OutcomeBaroreflexCardiac Resynchronization TherapyHSM CARINTRODUCTION: Baroreflex function is an independent marker of prognosis in heart failure (HF). However, little is known about its relation to response to cardiac resynchronization therapy (CRT). The aim of this study is to assess arterial baroreflex function in HF patients who are candidates for CRT. METHODS: The study population consisted of 25 patients with indication for CRT, aged 65±10 years, NYHA functional class ≥III in 52%, QRS width 159±15 ms, left ventricular ejection fraction (LVEF) 29±5%, left ventricular end-systolic volume (LVESV) 150±48 ml, B-type natriuretic peptide (BNP) 357±270 pg/ml, and peak oxygen consumption (peak VO2) 18.4±5.0 ml/kg/min. An orthostatic tilt test was performed to assess the baroreflex effectiveness index (BEI) by the sequence method. This group was compared with 15 age-matched healthy individuals. RESULTS: HF patients showed a significantly depressed BEI during tilt (31±12% vs. 49±18%, p=0.001). A lower BEI was associated with higher BNP (p=0.038), lower peak VO2 (p=0.048), and higher LVESV (p=0.031). By applying a cut-off value of 25% for BEI, two clusters of patients were identified: lower risk cluster (BEI >25%) QRS 153 ms, LVESV 129 ml, BNP 146 pg/ml, peak VO2 19.0 ml/kg/min; and higher risk cluster (IEB ≤25%) QRS 167 ms, LVESV 189 ml, BNP 590 pg/ml, peak VO2 16.2 ml/kg/min. CONCLUSIONS: Candidates for CRT show depressed arterial baroreflex function. Lower BEI was observed in high-risk HF patients. Baroreflex function correlated closely with other clinical HF parameters. Therefore, BEI may improve risk stratification in HF patients undergoing CRT.Elsevier EspañaRepositório do Centro Hospitalar Universitário de Lisboa Central, EPESerôdio, JFOliveira, MMLaranjo, STavares, CCunha, PSAbreu, ABranco, LMAlves, SRocha, ICruz Ferreira, R2018-08-06T14:43:32Z2016-062016-06-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/3009engRev Port Cardiol. 2016 Jun;35(6):343-50.10.1016/j.repc.2015.11.021info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:40:47Zoai:repositorio.chlc.min-saude.pt:10400.17/3009Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:20:19.239568Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
The Arterial Baroreflex Effectiveness Index in Risk Stratification of Chronic Heart Failure Patients Who Are Candidates for Cardiac Resynchronization Therapy O Índice de Eficácia do Barorreflexo na Estratificação de Risco de Doentes com Insuficiência Cardíaca Crónica Candidatos à Terapêutica de Ressincronização Cardíaca |
title |
The Arterial Baroreflex Effectiveness Index in Risk Stratification of Chronic Heart Failure Patients Who Are Candidates for Cardiac Resynchronization Therapy |
spellingShingle |
The Arterial Baroreflex Effectiveness Index in Risk Stratification of Chronic Heart Failure Patients Who Are Candidates for Cardiac Resynchronization Therapy Serôdio, JF Aged Female Heart Failure Humans Male Middle Aged Natriuretic Peptide, Brain Risk Assessment Stroke Volume Treatment Outcome Baroreflex Cardiac Resynchronization Therapy HSM CAR |
title_short |
The Arterial Baroreflex Effectiveness Index in Risk Stratification of Chronic Heart Failure Patients Who Are Candidates for Cardiac Resynchronization Therapy |
title_full |
The Arterial Baroreflex Effectiveness Index in Risk Stratification of Chronic Heart Failure Patients Who Are Candidates for Cardiac Resynchronization Therapy |
title_fullStr |
The Arterial Baroreflex Effectiveness Index in Risk Stratification of Chronic Heart Failure Patients Who Are Candidates for Cardiac Resynchronization Therapy |
title_full_unstemmed |
The Arterial Baroreflex Effectiveness Index in Risk Stratification of Chronic Heart Failure Patients Who Are Candidates for Cardiac Resynchronization Therapy |
title_sort |
The Arterial Baroreflex Effectiveness Index in Risk Stratification of Chronic Heart Failure Patients Who Are Candidates for Cardiac Resynchronization Therapy |
author |
Serôdio, JF |
author_facet |
Serôdio, JF Oliveira, MM Laranjo, S Tavares, C Cunha, PS Abreu, A Branco, LM Alves, S Rocha, I Cruz Ferreira, R |
author_role |
author |
author2 |
Oliveira, MM Laranjo, S Tavares, C Cunha, PS Abreu, A Branco, LM Alves, S Rocha, I Cruz Ferreira, R |
author2_role |
author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE |
dc.contributor.author.fl_str_mv |
Serôdio, JF Oliveira, MM Laranjo, S Tavares, C Cunha, PS Abreu, A Branco, LM Alves, S Rocha, I Cruz Ferreira, R |
dc.subject.por.fl_str_mv |
Aged Female Heart Failure Humans Male Middle Aged Natriuretic Peptide, Brain Risk Assessment Stroke Volume Treatment Outcome Baroreflex Cardiac Resynchronization Therapy HSM CAR |
topic |
Aged Female Heart Failure Humans Male Middle Aged Natriuretic Peptide, Brain Risk Assessment Stroke Volume Treatment Outcome Baroreflex Cardiac Resynchronization Therapy HSM CAR |
description |
INTRODUCTION: Baroreflex function is an independent marker of prognosis in heart failure (HF). However, little is known about its relation to response to cardiac resynchronization therapy (CRT). The aim of this study is to assess arterial baroreflex function in HF patients who are candidates for CRT. METHODS: The study population consisted of 25 patients with indication for CRT, aged 65±10 years, NYHA functional class ≥III in 52%, QRS width 159±15 ms, left ventricular ejection fraction (LVEF) 29±5%, left ventricular end-systolic volume (LVESV) 150±48 ml, B-type natriuretic peptide (BNP) 357±270 pg/ml, and peak oxygen consumption (peak VO2) 18.4±5.0 ml/kg/min. An orthostatic tilt test was performed to assess the baroreflex effectiveness index (BEI) by the sequence method. This group was compared with 15 age-matched healthy individuals. RESULTS: HF patients showed a significantly depressed BEI during tilt (31±12% vs. 49±18%, p=0.001). A lower BEI was associated with higher BNP (p=0.038), lower peak VO2 (p=0.048), and higher LVESV (p=0.031). By applying a cut-off value of 25% for BEI, two clusters of patients were identified: lower risk cluster (BEI >25%) QRS 153 ms, LVESV 129 ml, BNP 146 pg/ml, peak VO2 19.0 ml/kg/min; and higher risk cluster (IEB ≤25%) QRS 167 ms, LVESV 189 ml, BNP 590 pg/ml, peak VO2 16.2 ml/kg/min. CONCLUSIONS: Candidates for CRT show depressed arterial baroreflex function. Lower BEI was observed in high-risk HF patients. Baroreflex function correlated closely with other clinical HF parameters. Therefore, BEI may improve risk stratification in HF patients undergoing CRT. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-06 2016-06-01T00:00:00Z 2018-08-06T14:43:32Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.17/3009 |
url |
http://hdl.handle.net/10400.17/3009 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Rev Port Cardiol. 2016 Jun;35(6):343-50. 10.1016/j.repc.2015.11.021 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier España |
publisher.none.fl_str_mv |
Elsevier España |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799131299724656640 |